At Kauvery Cancer Institute, we are proud to offer advanced radiotherapy with the Varian TrueBeam Linear Accelerator, elevating treatment precision, patient comfort, and clinical outcomes across a broad spectrum of cancers.

The Clinical Edge of Varian TrueBeam Radiotherapy

TrueBeam represents one of the most significant advances in external-beam radiotherapy platforms globally and aligns with our commitment to delivering cutting-edge oncology care that is both effective and patient-centric.

Precision-Driven Tumor Targeting

The TrueBeam system integrates high-resolution imaging with synchronous radiation delivery to localize and treat tumors with millimeter-level accuracy.

1. Image-Guided Radiotherapy (IGRT): Daily 3D imaging and motion management enable clinicians to visualize tumor position immediately before and even during treatment, improving targeting reliability and minimizing geographic miss.
2. Motion Compensation: TrueBeam’s motion management capabilities, including respiratory gating and breath-hold support, allow treatment of tumors affected by breathing motion, critical for lung, breast, and upper abdominal cancers.
3. This precision reduces radiation exposure to healthy tissues and critical organs, translating to fewer acute and late toxicities and better preservation of patient function.

Versatile Clinical Applications

TrueBeam supports a full range of advanced external-beam techniques from conventional radiotherapy to highly conformal approaches:

1. IMRT & VMAT/Rapid Arc: Facilitates complex dose sculpting that conforms tightly to irregular tumor shapes.
2. Stereotactic Body Radiotherapy (SBRT) & Stereotactic Radiosurgery (SRS): Enables ultra-precise, high-dose treatments for small tumors in the lung, liver, spine, and brain with few fractions.
3. Adaptability Across Tumor Sites: Head and neck, breast, prostate, lung, gastrointestinal and CNS tumors can be treated with tailored protocols.
4. This versatility allows individualized treatment planning, facilitating curative intent where feasible and palliative care when appropriate.

Enhanced Efficiency and Treatment Experience

TrueBeam’s high dose-rate delivery markedly shortens session times, enhancing patient convenience and throughput.

1. Rapid Dose Delivery: Capable of delivering radiation up to ~2400 MU/min, roughly twice that of standard systems, allowing many daily fractions to be completed in minutes rather than tens of minutes.
2. Patient Comfort: Reduced on-table time decreases patient discomfort and lessens motion during treatment, further improving precision and tolerability.

Non-Invasive with Broad Accessibility

Radiation delivered by TrueBeam is entirely non-surgical, eliminating the risks and recovery associated with operative interventions. Patients can undergo therapy with minimal interruption to daily life.
This non-invasive approach broadens treatment options for patients who may be poor surgical candidates due to comorbidities or tumor location.

 Clinical Impact at Kauvery Cancer Institute

At Kauvery Cancer Institute, the TrueBeam facility enhances our multidisciplinary oncology pathways by:

1. Enabling precise dose escalation for improved local control while safeguarding organs at risk.
2. Offering SBRT/SRS options that can reduce overall treatment burden compared with conventional fractionation.
3. Supporting complex re-irradiation strategies by leveraging its imaging and motion management tools.
4. Facilitating efficient workflows for high-volume clinics without compromising quality.

Advanced Brachytherapy with Varian GammaMed^® HDR

Complementing our external beam capabilities, Kauvery Cancer Institute is equipped with the Varian GammaMed High-Dose-Rate (HDR) Brachytherapy system, enabling highly localized internal radiation delivery. Unlike external beam radiotherapy, HDR brachytherapy places a radioactive source directly within or adjacent to the tumor using image-guided applicators. This approach allows very high radiation doses to the tumor while achieving rapid dose fall-off, thereby sparing surrounding normal tissues.

GammaMed HDR plays a pivotal role in the management of cervical, endometrial, vaginal, prostate, breast (APBI), head & neck, and selected soft-tissue tumors, and is particularly integral to curative treatment protocols in gynecologic oncology.

The system’s remote after loading technology ensures precise source positioning with millimetric control and enhanced radiation safety for patients and staff. By integrating HDR brachytherapy with image-guided external beam radiotherapy on TrueBeam, Kauvery Cancer Institute delivers a comprehensive, multimodality radiation oncology platform aligned with contemporary evidence-based standards.

 Conclusion

The integration of Varian TrueBeam technology and GammaMed HDR Brachytherapy into Kauvery Cancer Institute’s therapeutic armamentarium reinforces our mission to provide high-precision, evidence-aligned radiotherapy. By combining cutting-edge imaging, dynamic motion management, and versatile dose delivery, TrueBeam improves clinical capability, enhances patient experience, and supports superior oncologic outcomes across a diverse patient population.

 Authored By:

Dr. B. Satish, Consultant – Radiation Oncology, Kauvery Cancer Institute, Trichy.

Dr. B. Sathish is a highly qualified Radiation Oncologist based in Trichy – Tennur, with extensive training and experience in the field. He completed his MBBS and MD in Radio Oncology at the Jawaharlal Institute of Postgraduate Medical Education & Research, followed by a DNB in Radio Therapy from the National Board of Examination. Dr. Sathish is dedicated to delivering comprehensive cancer care, utilizing advanced technologies and techniques to enhance treatment efficacy and improve patient quality of life.